×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Narayana Hrudayalaya Limited | 9595.77 | 873.71 | 9431.41 | 4.3 | 36,472 | 46.1 |
| IPCA LABORATORIES LTD. | 17719.2 | 2620.4 | 17469.0 | 10.33 | 33499 | 37.4 |
| Aster DM Healthcare Limited | 6514.7 | 805.9 | 6130.4 | 1.57 | 33103 | 93.6 |
Narayana Hrudayalaya Limited, with Security Code 539551, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 783.7 | 796.8 | 852.0 | 770.6 | 846.3 | 871.8 | 934.3 | 865.0 | 919.0 | 943.1 |
| Expenses | 665.4 | 659.1 | 688.4 | 632.7 | 689.8 | 715.2 | 751.8 | 708.4 | 743.2 | 764.1 |
| Operating Profit | 118.3 | 137.7 | 163.7 | 137.8 | 156.5 | 156.6 | 182.5 | 156.7 | 175.8 | 179.0 |
| OPM % | 15.1% | 17.28% | 19.21% | 17.89% | 18.49% | 17.96% | 19.54% | 18.11% | 19.13% | 18.98% |
| Other Income | 61.4 | 9.4 | 14.0 | 10.6 | 89.4 | 13.6 | 13.2 | 8.7 | 106.7 | 16.4 |
| Interest | 13.5 | 13.4 | 13.1 | 13.2 | 14.5 | 20.4 | 20.5 | 21.3 | 25.6 | 30.6 |
| Depreciation | 39.0 | 37.7 | 38.7 | 40.5 | 44.4 | 39.4 | 41.5 | 42.6 | 45.8 | 47.6 |
| Profit before tax | 127.3 | 96.0 | 125.8 | 94.7 | 187.0 | 110.5 | 133.8 | 101.4 | 211.1 | 117.3 |
| Tax % | -27.8% | -17.8% | -13.4% | -16.9% | -15.5% | 21.8% | -21.1% | -21.9% | -24.2% | 25.5% |
| Net Profit | 91.9 | 78.9 | 108.9 | 78.7 | 158.1 | 86.4 | 105.5 | 79.2 | 160.0 | 87.4 |
| EPS in Rs | 4.52 | 3.89 | 5.36 | 3.87 | 7.78 | 4.25 | 5.2 | 3.9 | 0 | 4.3 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,128.2 | 1,221.6 | 1,233.4 | 1,305.2 | 1,203.6 | 1,279.4 | 1,341.0 | 1,400.0 | 1,366.7 | 1,475.4 |
| Expenses | 873.7 | 945.8 | 962.8 | 997.1 | 924.7 | 984.8 | 1,037.1 | 1,091.6 | 1,059.7 | 1,117.6 |
| Operating Profit | 254.4 | 275.7 | 270.7 | 308.1 | 278.9 | 294.6 | 303.9 | 308.4 | 307.0 | 357.8 |
| OPM % | 22.55% | 22.57% | 21.95% | 23.61% | 23.18% | 23.02% | 22.66% | 22.03% | 22.46% | 24.25% |
| Other Income | 11.5 | 14.7 | 15.1 | 18.4 | 17.9 | 23.9 | 23.5 | 23.6 | 18.4 | 18.5 |
| Interest | 18.7 | 20.6 | 20.9 | 22.9 | 25.1 | 28.0 | 34.0 | 35.1 | 36.6 | 40.7 |
| Depreciation | 57.3 | 56.3 | 58.9 | 55.3 | 63.2 | 64.8 | 61.7 | 65.1 | 70.0 | 82.5 |
| Profit before tax | 189.9 | 213.5 | 205.9 | 248.4 | 208.6 | 225.6 | 231.7 | 231.8 | 218.8 | 261.5 |
| Tax % | -19% | -18.9% | -10.6% | -8.7% | -9.8% | -15.4% | -13% | 14.2% | -11.8% | -22.4% |
| Net Profit | 153.9 | 173.2 | 184.0 | 226.7 | 188.1 | 190.8 | 201.5 | 198.8 | 193.1 | 197.3 |
| EPS in Rs | 7.57 | 8.53 | 9.06 | 11.16 | 9.26 | 9.39 | 9.92 | 9.78 | 9.5 | 0.05 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 9% |
| 3 Years: | 25% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 53% |
| 3 Years: | 98% |
| TTM: | 20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 45% |
| 3 Years: | 41% |
| 1 Year: | 37% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 12% |
| 3 Years: | 25% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 51% |
| 5 Years: | 68% |
| 3 Years: | 365% |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 45% |
| 3 Years: | 41% |
| 1 Year: | 37% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|